Clinical Research Directory

PAlliative RAdioTherapy to Lung Cancer A Randomized Multicentre Phase III Study

Sponsor: University of Aarhus

Summary

The aim of this study is to examine if a shorter palliative radiotherapy fractionation scheme of 20 Gy / 4 F can reduce the early oesophageal toxicity compared to 30 Gy / 10 F in patients with lung cancer in performance status (PS) 0-2. Secondary aims are to examine the effect on lung cancer symptoms, quality of life (QoL) and survival. Furthermore, the investigators aim at standardizing the quality of palliative thoracic radiotherapy in all Danish centres at the highest technical level.

Official title: PARAT PAlliative RAdioTherapy to Lung Cancer A Randomized Multicentre Phase III Study

Key Details

Conditions

Interventions

Locations (1)